Reduced regenerative capacity of aged stem cells hampers the benefits of autologous cell therapy for cardiac regeneration. This study investigated whether neuron-derived neurotrophic factor (NDNF) could rejuvenate aged human bone marrow (hBM)- multipotent mesenchymal stromal cells (MSCs) and whether the rejuvenated hBM-MSCs could improve cardiac repair after ischemic injury. Over-expression of NDNF in old hBM-MSCs decreased cell senescence and apoptosis. Engraftment of NDNF over-expressing old hBM-MSCs into the ischemic area of mouse hearts resulted in improved cardiac function after myocardial infarction, while promoting implanted stem cell survival. Our findings suggest NDNF could be a new factor to rejuvenate aged stem cells and improve their capability to repair the aged heart after injury.
Keywords: CDC, cardiosphere-derived cell; MI, myocardial infarction; MSC, multipotent mesenchymal stromal cell; NDNF; NDNF, neuron-derived neurotrophic factor; RGN, regucalcin; aging; hBM, human bone marrow; heart function; human stem cells; mRNA, messenger ribonucleic acid; myocardial infarction; p-Akt, phosphorylated Akt; rejuvenation.